drugset

drugset / Trial / NCT02844283

Ad-HGF Treatment for Myocardial Infarction

NCT02844283 ↗

Phase 1/2 Unknown 100 enrolled The First Affiliated Hospital with Nanjing Medical University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This will be the first clinical trial use Ad-HGF gene for the treatment of myocardial infarction disease.

Timeline

Start: 2016-11
Primary completion: 2018-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ad-HGF	Unknown	—	Other

Indications